Biotoxtech Co. Ltd Cash Flow Quality Index
Biotoxtech Co. Ltd cash flow quality index. Biotoxtech Co. Ltd (086040) has a Cash Flow Quality Index of -0.06x as of September 2025. Operating cash flow of ₩-354.72 Million is below net income of ₩5.51 Billion, suggesting accrual-heavy earnings not yet converted to cash. See Biotoxtech Co. Ltd (086040) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Biotoxtech Co. Ltd (2011–2025)
Cash flow quality index of Biotoxtech Co. Ltd from 2011 to 2025. Historical Cash Flow Quality Index for Biotoxtech Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Biotoxtech Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Biotoxtech Co. Ltd Cash Flow Quality Index by Year (2011–2025)
Biotoxtech Co. Ltd cash flow quality index by year from 2011 to 2025. Year-by-year earnings quality comparison for Biotoxtech Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of Biotoxtech Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.71x | ₩6.64 Billion | ₩1.16 Billion | ▲ +1288.1% |
| 2022 | -0.48x | ₩-1.31 Billion | ₩2.73 Billion | ▼ -178.6% |
| 2021 | 0.61x | ₩4.35 Billion | ₩7.11 Billion | ▼ -65.0% |
| 2020 | 1.75x | ₩4.56 Billion | ₩2.61 Billion | ▲ +106.7% |
| 2018 | 0.84x | ₩3.06 Billion | ₩3.62 Billion | ▼ -80.5% |
| 2017 | 4.33x | ₩6.02 Billion | ₩1.39 Billion | ▼ -5.0% |
| 2016 | 4.55x | ₩5.28 Billion | ₩1.16 Billion | ▲ +277.2% |
| 2012 | 1.21x | ₩1.63 Billion | ₩1.35 Billion | ▲ +20.4% |
| 2011 | 1.00x | ₩3.28 Billion | ₩3.27 Billion | — |